Characterization of a factor H mutation that perturbs the alternative pathway of complement in a family with membranoproliferative GN.
about
A De Novo Deletion in the Regulators of Complement Activation Cluster Producing a Hybrid Complement Factor H/Complement Factor H-Related 3 Gene in Atypical Hemolytic Uremic Syndrome.The role of ADAMTS-13 activity and complement mutational analysis in differentiating acute thrombotic microangiopathiesThrombotic Microangiopathy in Inverted Formin 2-Mediated Renal Disease.A haplotype in CFH family genes confers high risk of rare glomerular nephropathies.Kidney Disease Caused by Dysregulation of the Complement Alternative Pathway: An Etiologic Approach.C3 glomerulopathy.Update on C3 glomerulopathy.Disease-linked mutations in factor H reveal pivotal role of cofactor activity in self-surface-selective regulation of complement activation.Complement C5-inhibiting therapy for the thrombotic microangiopathies: accumulating evidence, but not a panacea.Diseases of complement dysregulation-an overview.Functional Characterization of the Disease-Associated N-Terminal Complement Factor H Mutation W198R.
P2860
Q33426927-B954B791-3430-4EA4-82EE-B87B8582C61EQ33427495-5A16ECB0-74EA-4694-B151-4ADDB6E6BC11Q33437631-6758E9DD-1B76-4A07-980E-F9B6FFAC04B9Q33920982-739447FA-6567-4727-8EDA-00585A2FAFF8Q38549182-33FEDE0D-AD3C-4589-84C7-0DFB6F5ACC54Q39207807-3C30F8D8-F7E2-4C3A-90B2-8EC56F4ABE46Q40744602-E57234E9-8953-4ED9-A1A9-A66C78878B82Q41377869-B3A7AD1B-998B-4B87-955F-FE4BFAE27D7BQ42086661-8EF35322-4BE1-4B81-B777-D1F0A2737632Q48256943-7BBD01DC-BFF7-44B1-A999-30ADEEFC878DQ50100348-BD7C01CA-367D-4F16-9061-AC1C7911BD68
P2860
Characterization of a factor H mutation that perturbs the alternative pathway of complement in a family with membranoproliferative GN.
description
2014 nî lūn-bûn
@nan
2014 թուականի Ապրիլին հրատարակուած գիտական յօդուած
@hyw
2014 թվականի ապրիլին հրատարակված գիտական հոդված
@hy
2014年の論文
@ja
2014年論文
@yue
2014年論文
@zh-hant
2014年論文
@zh-hk
2014年論文
@zh-mo
2014年論文
@zh-tw
2014年论文
@wuu
name
Characterization of a factor H ...... with membranoproliferative GN.
@ast
Characterization of a factor H ...... with membranoproliferative GN.
@en
Characterization of a factor H ...... with membranoproliferative GN.
@nl
type
label
Characterization of a factor H ...... with membranoproliferative GN.
@ast
Characterization of a factor H ...... with membranoproliferative GN.
@en
Characterization of a factor H ...... with membranoproliferative GN.
@nl
prefLabel
Characterization of a factor H ...... with membranoproliferative GN.
@ast
Characterization of a factor H ...... with membranoproliferative GN.
@en
Characterization of a factor H ...... with membranoproliferative GN.
@nl
P2093
P2860
P50
P356
P1476
Characterization of a factor H ...... with membranoproliferative GN.
@en
P2093
Alison Macleod
Andrew P Herbert
Ann Humphrey
Anna Richards
Claire L Harris
Daniel Ahlert
Edwin K S Wong
Geisilaine S Reis
Holly E Anderson
James O Tellez
P2860
P304
P356
10.1681/ASN.2013070732
P577
2014-04-10T00:00:00Z